The Journal of Heart and Lung Transplantation
International Society for Heart and Lung Transplantation.
Original Clinical Science|Articles in Press

Early posttransplant reductions in club cell secretory protein associate with future risk for chronic allograft dysfunction in lung recipients: results from a multicenter study

Published:February 27, 2023DOI:


      Chronic lung allograft dysfunction (CLAD) increases morbidity and mortality for lung transplant recipients. Club cell secretory protein (CCSP), produced by airway club cells, is reduced in the bronchoalveolar lavage fluid (BALF) of lung recipients with CLAD. We sought to understand the relationship between BALF CCSP and early posttransplant allograft injury and determine if early posttransplant BALF CCSP reductions indicate later CLAD risk.


      We quantified CCSP and total protein in 1606 BALF samples collected over the first posttransplant year from 392 adult lung recipients at 5 centers. Generalized estimating equation models were used to examine the correlation of allograft histology or infection events with protein-normalized BALF CCSP. We performed multivariable Cox regression to determine the association between a time-dependent binary indicator of normalized BALF CCSP level below the median in the first posttransplant year and development of probable CLAD.


      Normalized BALF CCSP concentrations were 19% to 48% lower among samples corresponding to histological allograft injury as compared with healthy samples. Patients who experienced any occurrence of a normalized BALF CCSP level below the median over the first posttransplant year had a significant increase in probable CLAD risk independent of other factors previously linked to CLAD (adjusted hazard ratio 1.95; p = 0.035).


      We discovered a threshold for reduced BALF CCSP to discriminate future CLAD risk; supporting the utility of BALF CCSP as a tool for early posttransplant risk stratification. Additionally, our finding that low CCSP associates with future CLAD underscores a role for club cell injury in CLAD pathobiology.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The Journal of Heart and Lung Transplantation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Chambers DC
        • Zuckermann A
        • Cherikh WS
        • et al.
        The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 37th adult lung transplantation report - 2020; focus on deceased donor characteristics.
        J Heart Lung Transplant. 2020; 39: 1016-1027
        • Ofek E
        • Sato M
        • Saito T
        • et al.
        Restrictive allograft syndrome post lung transplantation is characterized by pleuroparenchymal fibroelastosis.
        Mod Pathol. 2013; 26: 350-356
        • von der Thusen JH
        • Vandermeulen E
        • Vos R
        • Weynand B
        • Verbeken EK
        • Verleden SE.
        The histomorphological spectrum of restrictive chronic lung allograft dysfunction and implications for prognosis.
        Mod Pathol. 2018; 31: 780-790
        • Verleden GM
        • Glanville AR
        • Lease ED
        • et al.
        Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment-a consensus report from the Pulmonary Council of the ISHLT.
        J Heart Lung Transplant. 2019; 38: 493-503
        • Kelly FL
        • Kennedy VE
        • Jain R
        • et al.
        Epithelial clara cell injury occurs in bronchiolitis obliterans syndrome after human lung transplantation.
        Am J Transplant. 2012; 12: 3076-3084
        • Liu Z
        • Liao F
        • Scozzi D
        • et al.
        An obligatory role for club cells in preventing obliterative bronchiolitis in lung transplants.
        JCI Insight. 2019; 5e124732
        • Wang SZ
        • Rosenberger CL
        • Bao YX
        • Stark JM
        • Harrod KS.
        Clara cell secretory protein modulates lung inflammatory and immune responses to respiratory syncytial virus infection.
        J Immunol. 2003; 171: 1051-1060
        • Hayashida S
        • Harrod KS
        • Whitsett JA.
        Regulation and function of CCSP during pulmonary Pseudomonas aeruginosa infection in vivo.
        Am J Physiol Lung Cell Mol Physiol. 2000; 279: L452-L459
        • Mango GW
        • Johnston CJ
        • Reynolds SD
        • Finkelstein JN
        • Plopper CG
        • Stripp BR.
        Clara cell secretory protein deficiency increases oxidant stress response in conducting airways.
        Am J Physiol. 1998; 275: L348-L356
        • Bustos ML
        • Mura M
        • Hwang D
        • et al.
        Depletion of bone marrow CCSP-expressing cells delays airway regeneration.
        Mol Ther. 2015; 23: 561-569
        • Hong KU
        • Reynolds SD
        • Giangreco A
        • Hurley CM
        • Stripp BR.
        Clara cell secretory protein-expressing cells of the airway neuroepithelial body microenvironment include a label-retaining subset and are critical for epithelial renewal after progenitor cell depletion.
        Am J Respir Cell Mol Biol. 2001; 24: 671-681
        • Snyder LD
        • Belperio J
        • Budev M
        • et al.
        Highlights from the clinical trials in organ transplantation (CTOT)-20 and CTOT-22 Consortium studies in lung transplant.
        Am J Transplant. 2020; 20: 1489-1494
        • Martinu T
        • Koutsokera A
        • Benden C
        • et al.
        International Society for Heart and Lung Transplantation consensus statement for the standardization of bronchoalveolar lavage in lung transplantation.
        J Heart Lung Transplant. 2020; 39: 1171-1190
        • Stewart S
        • Fishbein MC
        • Snell GI
        • et al.
        Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection.
        J Heart Lung Transplant. 2007; 26: 1229-1242
        • Pavlisko EN
        • Neely ML
        • Kopetskie H
        • et al.
        Prognostic implications of and clinical risk factors for acute lung injury and organizing pneumonia after lung transplantation: data from a multicenter prospective cohort study.
        Am J Transplant. 2022; 22: 3002-3011
        • Snapinn SM
        • Jiang Q
        • Iglewicz B.
        Illustrating the impact of a time-varying covariate with an extended kaplan-meier estimator.
        Am Stat. 2005; 59: 301-307
        • Nord M
        • Schubert K
        • Cassel TN
        • Andersson O
        • Riise GC.
        Decreased serum and bronchoalveolar lavage levels of Clara cell secretory protein (CC16) is associated with bronchiolitis obliterans syndrome and airway neutrophilia in lung transplant recipients.
        Transplantation. 2002; 73: 1264-1269
        • Diamond JM
        • Kawut SM
        • Lederer DJ
        • et al.
        Elevated plasma clara cell secretory protein concentration is associated with high-grade primary graft dysfunction.
        Am J Transplant. 2011; 11: 561-567
        • Shah RJ
        • Wickersham N
        • Lederer DJ
        • et al.
        Preoperative plasma club (clara) cell secretory protein levels are associated with primary graft dysfunction after lung transplantation.
        Am J Transplant. 2014; 14: 446-452
        • Bourdin A
        • Mifsud NA
        • Chanez B
        • et al.
        Donor clara cell secretory protein polymorphism is a risk factor for bronchiolitis obliterans syndrome after lung transplantation.
        Transplantation. 2012; 94: 652-658
        • Wang SZ
        • Rosenberger CL
        • Espindola TM
        • et al.
        CCSP modulates airway dysfunction and host responses in an Ova-challenged mouse model.
        Am J Physiol Lung Cell Mol Physiol. 2001; 281: L1303-L1311
        • Johnson MDL
        • Younis US
        • Menghani SV
        • et al.
        CC16 Binding to alpha4beta1 Integrin Protects against Mycoplasma pneumoniae Infection.
        Am J Respir Crit Care Med. 2021; 203: 1410-1418
        • Mittelbrunn M
        • Molina A
        • Escribese MM
        • et al.
        VLA-4 integrin concentrates at the peripheral supramolecular activation complex of the immune synapse and drives T helper 1 responses.
        Proc Natl Acad Sci U S A. 2004; 101: 11058-11063
        • Levine CR
        • Gewolb IH
        • Allen K
        • et al.
        The safety, pharmacokinetics, and anti-inflammatory effects of intratracheal recombinant human Clara cell protein in premature infants with respiratory distress syndrome.
        Pediatr Res. 2005; 58: 15-21